Faculty Disclosures
| John Venditto |
John Venditto has received personal compensation for serving as an employee of AstraZeneca . John Venditto has stock in AstraZeneca . |
| David M. Sletten, MBA |
Mr. Sletten has nothing to disclose. |
| Amanda Lee |
Ms. Lee has nothing to disclose. |
| Erika Ivey, MS |
Miss Ivey has nothing to disclose. |
| Meredith A. Bryarly, MD |
The institution of Dr. Bryarly has received research support from Theravance. |
| Howard L. Weiner, MD |
Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc.. |
| Mazen Hanna |
No disclosure on file
|
| Shipra Dubey |
Shipra Dubey has nothing to disclose. |
| Jade Gehrking |
Jade Gehrking has nothing to disclose. |
| Phillip A. Low, MD, FAAN |
Dr. Low has nothing to disclose. |
| Mitchell G. Miglis, MD, FAAN |
Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care. |
| Alain Ndayisaba, MD |
Dr. Ndayisaba has nothing to disclose. |
| Anasheh Halabi, MD, PhD |
Dr. Halabi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Halabi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Halabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Halabi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PeerVoice. Dr. Halabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas/Pfizer. Dr. Halabi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ADVI. Dr. Halabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Halabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Halabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. The institution of Dr. Halabi has received research support from Pharnext. The institution of Dr. Halabi has received research support from AstraZeneca. |
| Steven Cicero, BS |
Steven Cicero has nothing to disclose. |
| Vikram Khurana, MD, PhD |
Dr. Khurana has received personal compensation for serving as an employee of DaCapo BrainScience. An immediate family member of Dr. Khurana has received personal compensation for serving as an employee of Arbor Therapeutics. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda Pharmaceuticals. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Khurana has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DaCapo Brainscience. Dr. Khurana has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. Dr. Khurana has stock in DaCapo Brainscience. The institution of Dr. Khurana has received research support from Sanofi. The institution of Dr. Khurana has received research support from Janssen. The institution of Dr. Khurana has received research support from Biohaven. The institution of Dr. Khurana has received research support from Tiziana Life Sciences. Dr. Khurana has received intellectual property interests from a discovery or technology relating to health care. |
| Benjamin D. Levine, MD |
Dr. Levine has nothing to disclose. |
| Wolfgang Singer, MD, FAAN |
Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care. |
| Ashlan Willett, MSc |
Mr. Willett has nothing to disclose. |
| Meghan Towne |
No disclosure on file
|
| Denis J. Wakeham, PhD |
The institution of Dr. Wakeham has received research support from Bank of America Fichtenbaum Charitable Trust. The institution of Dr. Wakeham has received research support from Wilderness Medical Society. |
| Ariana T. Pitaro |
Ms. Pitaro has nothing to disclose. |
| Mia Papas, PhD |
Dr. Papas has received personal compensation for serving as an employee of AstraZeneca. Dr. Papas has stock in AstraZeneca. |
| Victor Liaw, MD |
Mr. Liaw has nothing to disclose. |
| Xitong Li, PhD |
Dr. Li has received personal compensation for serving as an employee of NextGen Jane. Dr. Li has received intellectual property interests from a discovery or technology relating to health care. |
| Hyunji Kim, MD |
Dr. Kim has nothing to disclose. |
| Hemanth D. Nair, PhD |
Dr. Nair has received personal compensation for serving as an employee of Clarivate. Dr. Nair has stock in Clarivate. |
| Tarun Singhal, MD |
Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana LifeSciences. The institution of Dr. Singhal has received research support from Novartis. The institution of Dr. Singhal has received research support from Department of Defense. The institution of Dr. Singhal has received research support from Foundation for Neurologic Diseases. |
| Melissa M. Cortez, DO |
The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project. |
| Marie Davies |
No disclosure on file
|
| Shannon Grappe, NP |
Ms. Grappe has nothing to disclose. |
| Geoffrey Young, MD |
The institution of Dr. Young has received research support from NIH. The institution of Dr. Young has received research support from Open Philanthropy. The institution of Dr. Young has received research support from Siemens Healthineers. Dr. Young has received intellectual property interests from a discovery or technology relating to health care. Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Max Planck Institute. |
| Steven Vernino, MD, PhD, FAAN |
Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron. |
| Amber Salter, PhD |
Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers. |
| Caitlin Reese, PhD |
Dr. Reese has nothing to disclose. |
| Hong Pan, PhD |
Dr. Pan has nothing to disclose. |
| Victoria Sanjurjo, MD |
No disclosure on file
|
| James B. Young, MPH |
Mr. Young has received personal compensation for serving as an employee of Clarivate. Mr. Young has stock in Clarivate. |
| Steve Hopkins |
Steve Hopkins has nothing to disclose. |
| Tonette Gehrking |
Tonette Gehrking has nothing to disclose. |
| Amy Shea |
No disclosure on file
|
| Diego Rodriguez, Sr., MD |
No disclosure on file
|
| Eero Rissanen, MD |
Dr. Rissanen has received research support from Sigrid Juselius Foundation. |
| Nicolas Horan |
Mr. Horan has nothing to disclose. |
| Olivia Laun |
Ms. Laun has nothing to disclose. |
| Eric T. Hedge, PhD |
Dr. Hedge has nothing to disclose. |